## **Core Concept**
Megaloblastic anemia is a condition characterized by the production of abnormally large red blood cells that are not able to function properly. It is primarily caused by a deficiency in either **vitamin B12** or **folic acid**, as both are crucial for DNA synthesis in rapidly dividing cells, such as those found in the bone marrow.

## **Why the Correct Answer is Right**
The correct approach to treating megaloblastic anemia involves administering both **folic acid** and **vitamin B12** because:
- **Vitamin B12** and **folic acid** are both essential for the synthesis of DNA.
- A deficiency in either can lead to megaloblastic anemia.
- Treatment with both ensures that the underlying cause, whether it be a deficiency in one or both, is addressed.
- Administering **folic acid** alone can correct the hematological manifestations of **vitamin B12** deficiency but not its neurological complications.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because giving only **folic acid** might improve the hematological symptoms of megaloblastic anemia caused by **vitamin B12** deficiency but will not prevent or treat the neurological complications associated with **vitamin B12** deficiency.
- **Option B:** This option is incorrect because giving only **vitamin B12** will not address a potential **folic acid** deficiency, which could also be causing megaloblastic anemia.
- **Option C:** This option is incorrect for similar reasons as **Option A** and **Option B**; it suggests giving one without considering the potential deficiency of the other.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **vitamin B12** deficiency can cause neurological symptoms (such as neuropathy) in addition to megaloblastic anemia, and **folic acid** cannot prevent these neurological manifestations. Therefore, it's critical to test for both **vitamin B12** and **folic acid** deficiencies in patients with megaloblastic anemia and treat accordingly.

## **Correct Answer:** D. Both.